BIOMAT Database Logo BIOMAT Database Logo

Benzo[1,2-c]1,2,5-oxadiazole N-oxide derivatives as potential antitrypanosomal drugs. Part 3: Substituents-clustering methodology in the search for new active compounds. 2005

Gabriela Aguirre, and Lucía Boiani, and Hugo Cerecetto, and Rossanna Di Maio, and Mercedes González, and Williams Porcal, and Ana Denicola, and Matías Möller, and Leonor Thomson, and Verónica Tórtora
Departamento de Química Orgánica, Facultad de Química-Facultad de Ciencias, Universidad de la República, Montevideo, Uruguay.

The results of a study on the use of Hansch's series design, cluster methodology, for the generation of new benzo[1,2-c]1,2,5-oxadiazole N-oxide derivatives as antitrypanosomal compounds are described. In vitro activity of these compounds was tested against Tulahuen 2 strain of Trypanosoma cruzi. Clearly, the Hansch methodology allowed identifying two cluster-substituents suitable for further structural modifications. The most effective drugs, derivatives 11, 18, and 21, with 50% inhibitory concentration (IC(50)) of the same order as that of the reference drug, represent an excellent structural point of chemical modifications for the design of future drugs. Preliminary results from the study of the mechanism of action of these benzofuroxans point to perturbation of the mitochondrial electron chain, inhibiting parasite respiration.

UI MeSH Term Description Entries
D009547 Nifurtimox A nitrofuran thiazine that has been used against TRYPANOSOMIASIS. Bayer 2502,Lampit
D010069 Oxadiazoles Compounds containing five-membered heteroaromatic rings containing two carbons, two nitrogens, and one oxygen atom which exist in various regioisomeric forms. Oxadiazole
D010084 Oxidation-Reduction A chemical reaction in which an electron is transferred from one molecule to another. The electron-donating molecule is the reducing agent or reductant; the electron-accepting molecule is the oxidizing agent or oxidant. Reducing and oxidizing agents function as conjugate reductant-oxidant pairs or redox pairs (Lehninger, Principles of Biochemistry, 1982, p471). Redox,Oxidation Reduction
D010087 Oxides Binary compounds of oxygen containing the anion O(2-). The anion combines with metals to form alkaline oxides and non-metals to form acidic oxides. Oxide
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D001554 Benzene Toxic, volatile, flammable liquid hydrocarbon byproduct of coal distillation. It is used as an industrial solvent in paints, varnishes, lacquer thinners, gasoline, etc. Benzene causes central nervous system damage acutely and bone marrow damage chronically and is carcinogenic. It was formerly used as parasiticide. Benzol,Benzole,Cyclohexatriene
D013329 Structure-Activity Relationship The relationship between the chemical structure of a compound and its biological or pharmacological activity. Compounds are often classed together because they have structural characteristics in common including shape, size, stereochemical arrangement, and distribution of functional groups. Relationship, Structure-Activity,Relationships, Structure-Activity,Structure Activity Relationship,Structure-Activity Relationships
D014344 Trypanocidal Agents Agents destructive to the protozoal organisms belonging to the suborder TRYPANOSOMATINA. Trypanocidal Drugs,Trypanocides,Trypanosomicidal Agents,Trypanosomicides,Agents, Trypanocidal,Agents, Trypanosomicidal,Drugs, Trypanocidal
D014349 Trypanosoma cruzi The agent of South American trypanosomiasis or CHAGAS DISEASE. Its vertebrate hosts are man and various domestic and wild animals. Insects of several species are vectors. Trypanosoma cruzus,cruzi, Trypanosoma
D015394 Molecular Structure The location of the atoms, groups or ions relative to one another in a molecule, as well as the number, type and location of covalent bonds. Structure, Molecular,Molecular Structures,Structures, Molecular

Related Publications

Gabriela Aguirre, and Lucía Boiani, and Hugo Cerecetto, and Rossanna Di Maio, and Mercedes González, and Williams Porcal, and Ana Denicola, and Matías Möller, and Leonor Thomson, and Verónica Tórtora
Benzo[1,2-c]1,2,5-oxadiazole N-oxide derivatives as potential antitrypanosomal drugs. Structure-activity relationships. Part II.
January 2002, Archiv der Pharmazie,
Gabriela Aguirre, and Lucía Boiani, and Hugo Cerecetto, and Rossanna Di Maio, and Mercedes González, and Williams Porcal, and Ana Denicola, and Matías Möller, and Leonor Thomson, and Verónica Tórtora
1,2,5-Oxadiazole N-oxide derivatives and related compounds as potential antitrypanosomal drugs: structure-activity relationships.
June 1999, Journal of medicinal chemistry,
Gabriela Aguirre, and Lucía Boiani, and Hugo Cerecetto, and Rossanna Di Maio, and Mercedes González, and Williams Porcal, and Ana Denicola, and Matías Möller, and Leonor Thomson, and Verónica Tórtora
1,2,5-Oxadiazole N-oxide derivatives as potential anti-cancer agents: synthesis and biological evaluation. Part IV.
October 2001, European journal of medicinal chemistry,
Gabriela Aguirre, and Lucía Boiani, and Hugo Cerecetto, and Rossanna Di Maio, and Mercedes González, and Williams Porcal, and Ana Denicola, and Matías Möller, and Leonor Thomson, and Verónica Tórtora
The study of NADPH-dependent flavoenzyme-catalyzed reduction of benzo[1,2-c]1,2,5-oxadiazole N-oxides (benzofuroxans).
December 2014, International journal of molecular sciences,
Gabriela Aguirre, and Lucía Boiani, and Hugo Cerecetto, and Rossanna Di Maio, and Mercedes González, and Williams Porcal, and Ana Denicola, and Matías Möller, and Leonor Thomson, and Verónica Tórtora
Electrochemical and microsomal production of free radicals from 1,2,5-oxadiazole N-oxide as potential antiprotozoal drugs.
January 2003, Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy,
Gabriela Aguirre, and Lucía Boiani, and Hugo Cerecetto, and Rossanna Di Maio, and Mercedes González, and Williams Porcal, and Ana Denicola, and Matías Möller, and Leonor Thomson, and Verónica Tórtora
Synthesis and biological evaluation of 1,2,5-oxadiazole N-oxide derivatives as potential hypoxic cytotoxins and DNA-binders.
November 2000, Archiv der Pharmazie,
Gabriela Aguirre, and Lucía Boiani, and Hugo Cerecetto, and Rossanna Di Maio, and Mercedes González, and Williams Porcal, and Ana Denicola, and Matías Möller, and Leonor Thomson, and Verónica Tórtora
Synthesis and biological evaluation of 1,2,5-oxadiazole N-oxide derivatives as hypoxia-selective cytotoxins.
November 1998, Die Pharmazie,
Gabriela Aguirre, and Lucía Boiani, and Hugo Cerecetto, and Rossanna Di Maio, and Mercedes González, and Williams Porcal, and Ana Denicola, and Matías Möller, and Leonor Thomson, and Verónica Tórtora
Syntheses, Biological Evaluations, and Mechanistic Studies of Benzo[c][1,2,5]oxadiazole Derivatives as Potent PD-L1 Inhibitors with In Vivo Antitumor Activity.
June 2021, Journal of medicinal chemistry,
Gabriela Aguirre, and Lucía Boiani, and Hugo Cerecetto, and Rossanna Di Maio, and Mercedes González, and Williams Porcal, and Ana Denicola, and Matías Möller, and Leonor Thomson, and Verónica Tórtora
Novel 1,3,4-oxadiazole hybrids of 3-n-butylphthalide derivatives as potential anti-ischemic stroke agents.
December 2023, Bioorganic chemistry,
Gabriela Aguirre, and Lucía Boiani, and Hugo Cerecetto, and Rossanna Di Maio, and Mercedes González, and Williams Porcal, and Ana Denicola, and Matías Möller, and Leonor Thomson, and Verónica Tórtora
Synthesis of oxadiazole-2-oxide derivatives as potential drug candidates for schistosomiasis targeting SjTGR.
April 2021, Parasites & vectors,
Copied contents to your clipboard!